We examined 100 clinically significant isolates of Serratia marcescens for susceptibility to newer cephalosporin and cephamycin antibiotics, alone and in combination with various aminoglycosides. Moxalactam and cefotaxime were the most effective agents; all isolates were inhibited by 25 and 50 ,ug/ml, respectively. All strains were susceptible to amikacin at concentrations safely achievable in serum, whereas gentamicin, netilmicin, and tobramycin inhibited 63, 63, and 16% of the isolates, respectively. Moxalactam, cefotaxime, and amikacin were active against gentamicin-susceptible and gentamicin-resistant strains. Studies of synergy revealed that moxalactam and cefotaxime, in combination with netilmicin or amikacin, were often synergistic and infrequently antagonistic against cephalothin-and gentamicin-resistant strains. These results suggest that moxalactam and cefotaxime, alone or in combination, may be efficacious in treating infections due to multiply antibiotic-resistant S. marcescens.Over the past decade, Serratia marcescens has achieved preeminence as a cause of serious nosocomial infections (6,21,23,30). Susceptibility to aminoglycoside antibiotics was, at one time, taken for granted, but the emergence of multiply antibiotic-resistant strains has been a cause for concern (23,30).Cephalosporin antibiotics have been notoriously ineffective against S. marcescens. However, newer generations of cephalosporins, most notably moxalactam (LY127935) and cefotaxime (HR756), have been shown to be extremely active in vitro against both cephalothin-susceptible and cephalothin-resistant strains and some gentamicin-resistant organisms (7,8,10,13,24,27 Only strains judged to be involved in clinically significant infections were studied, including: (i) urinary isolates (36 strains) at more than 100,000 organisms per ml of urine on two consecutive daily urine cultures; (ii) wound isolates (21 strains) when S. marcescens was the only organism cultured from an infected area; (iii) sputum isolates (23 strains) when S. marcescens was consistently isolated in pure culture from a patient with purulent sputum, fever, and pulmonary infiltrates; (iv) blood (17 strains
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.